Connection

William Groh to Myotonic Dystrophy

Back to Details
This is a "connection" page, showing publications William Groh has written about Myotonic Dystrophy.
William Groh
Connection Strength
4.759
Myotonic Dystrophy
  1. 2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders. Heart Rhythm. 2022 10; 19(10):e61-e120.
    View in: PubMed
    Score: 0.771
  2. Myotonic Dystrophy and Conduction Disease. JACC Clin Electrophysiol. 2021 12; 7(12):1624.
    View in: PubMed
    Score: 0.749
  3. Arrhythmia management in myotonic dystrophy type 1. JAMA. 2012 Jul 25; 308(4):337-8; author reply 338.
    View in: PubMed
    Score: 0.392
  4. Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population. J Cardiovasc Electrophysiol. 2011 Dec; 22(12):1369-75.
    View in: PubMed
    Score: 0.372
  5. Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1. Am Heart J. 2010 Dec; 160(6):1137-41, 1141.e1.
    View in: PubMed
    Score: 0.349
  6. Arrhythmia exacerbation after sodium channel blockade in myotonic dystrophy type 1. Muscle Nerve. 2009 Nov; 40(5):901-2.
    View in: PubMed
    Score: 0.324
  7. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med. 2008 Jun 19; 358(25):2688-97.
    View in: PubMed
    Score: 0.295
  8. Familial clustering of muscular and cardiac involvement in myotonic dystrophy type 1. Muscle Nerve. 2005 Jun; 31(6):719-24.
    View in: PubMed
    Score: 0.239
  9. Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I. Am Heart J. 2004 Feb; 147(2):224-7.
    View in: PubMed
    Score: 0.218
  10. Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1. Ann Noninvasive Electrocardiol. 2003 Jul; 8(3):227-32.
    View in: PubMed
    Score: 0.209
  11. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol. 2002 May; 13(5):444-8.
    View in: PubMed
    Score: 0.193
  12. Clinical Care Recommendations for Cardiologists Treating Adults With Myotonic Dystrophy. J Am Heart Assoc. 2020 02 18; 9(4):e014006.
    View in: PubMed
    Score: 0.165
  13. A transgenic model of myotonic dystrophy: will the mouse roar? J Cardiovasc Electrophysiol. 1999 Sep; 10(9):1221-3.
    View in: PubMed
    Score: 0.160
  14. Rhythm management in myotonic dystrophy: Progress has been made, but unsettled issues remain. Heart Rhythm. 2018 07; 15(7):969-970.
    View in: PubMed
    Score: 0.145
  15. Survival and CTG repeat expansion in adults with myotonic dystrophy type 1. Muscle Nerve. 2011 May; 43(5):648-51.
    View in: PubMed
    Score: 0.090
  16. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. Neurology. 2011 Jan 25; 76(4):409; author reply 409.
    View in: PubMed
    Score: 0.088
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.